"We've seen an overwhelming response to the introduction of Cytation 3, as evidenced by the SelectScience Drug Discovery Product of the Year, and MipTec New Product Innovation awards that it's received so far," noted Gary Barush, BioTek's Director of Marketing and Sales. "And we've been able to react quickly to customer feedback with new imaging tools to further streamline imaging research."
40x and 60x objectives are now available options for any Cytation 3 application requiring increased magnification. These higher magnifications allow easy imaging of bacteria, yeast, and sub-cellular structures such as mitochondria. Additionally, 35 mm, 60 mm and 100 mm Petri dishes are now compatible, for expanded sample vessel convenience.
Cytation 3's Gen5™ Data Analysis Software offers additional tools to take your research to another level. With its broad image analysis capability, Gen5 software editions include options for 21 CFR Part 11 compliance or In Vitro Diagnostics use. Cytation 3 can be integrated with BioTek’s BioStack™ 4 Microplate Stacker to increase throughput of lidded and unlidded microplates.